| |
| |
|
| Insider
Information: |
Albright Charles |
| Relationship: |
EVP/Chief Scientific O... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
24,907 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$125,407 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
24,907 |
|
|
| Total
Value |
$125,407 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 231.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Editas Medicine, Inc. |
EDIT |
EVP/Chief Scientific O... |
2020-12-15 |
24,907 |
2018-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-12-15 |
4 |
AS |
$62.74 |
$632,156 |
D/D |
(10,000) |
24,907 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-12-15 |
4 |
OE |
$16.51 |
$165,100 |
D/D |
10,000 |
34,907 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-12-09 |
4 |
AS |
$45.00 |
$450,000 |
D/D |
(10,000) |
24,907 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-12-09 |
4 |
OE |
$16.51 |
$165,100 |
D/D |
10,000 |
34,907 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-12-07 |
4 |
OE |
$16.51 |
$330,200 |
D/D |
20,000 |
44,907 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-12-07 |
4 |
AS |
$40.02 |
$800,400 |
D/D |
(20,000) |
24,907 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-11-09 |
4 |
S |
$31.21 |
$7,116 |
D/D |
(228) |
24,907 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-10-15 |
4 |
AS |
$31.39 |
$94,170 |
D/D |
(3,000) |
25,135 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-08-17 |
4 |
AS |
$35.29 |
$352,900 |
D/D |
(10,000) |
28,135 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-08-17 |
4 |
OE |
$16.51 |
$165,100 |
D/D |
10,000 |
38,135 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-08-07 |
4 |
AS |
$34.99 |
$8,328 |
D/D |
(238) |
28,135 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-08-06 |
4 |
AS |
$37.47 |
$374,700 |
D/D |
(10,000) |
28,373 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-08-06 |
4 |
OE |
$16.51 |
$165,100 |
D/D |
10,000 |
38,373 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-07-15 |
4 |
AS |
$32.22 |
$96,660 |
D/D |
(3,000) |
28,373 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP/Chief Scientific Officer |
• – – |
2020-05-06 |
4 |
S |
$25.28 |
$3,817 |
D/D |
(151) |
31,373 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
Chief Scientific Officer |
• – – |
2020-02-07 |
4 |
S |
$26.95 |
$16,763 |
D/D |
(622) |
31,524 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
Chief Scientific Officer |
• – – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
11,593 |
32,146 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Scientific Officer |
• – – |
2020-02-03 |
4 |
S |
$26.54 |
$147,288 |
D/D |
(5,549) |
20,553 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
Chief Scientific Officer |
• – – |
2020-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,977 |
26,102 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Scientific Officer |
• – – |
2018-06-13 |
4 |
AS |
$35.98 |
$359,800 |
D/D |
(10,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Scientific Officer |
• – – |
2018-06-13 |
4 |
OE |
$16.51 |
$165,100 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Scientific Officer |
• – – |
2018-05-23 |
4 |
AS |
$35.00 |
$350,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Scientific Officer |
• – – |
2018-05-23 |
4 |
OE |
$16.51 |
$165,100 |
D/D |
10,000 |
10,000 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
